China Pharmaceutical Contract Manufacturing Services Market, 2020-2030

BAXTER SPRINGS, Kan. - July 30, 2020 - PRLog -- Roots Analysis is pleased to announce the publication of its recent study, titled, "China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 (https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html)."

The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features:

§  A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs).

§  A detailed landscape of the pharmaceutical manufacturing facilities in China, including an analysis based on location of these facilities, highlighting key manufacturing hubs.

§  A brief discussion of various regulatory guidelines in China and various challenges, related to regulatory scrutiny, faced by pharmaceutical manufacturers in China.

§  Detailed profiles of key players that offer a diverse range of capabilities for the manufacturing of pharmaceutical products in China.

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/china...

Other Recent Offerings

1.      China Biopharmaceutical Contract Manufacturing Market, 2020 – 2030

2.      HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030

3.      Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com